Does TADALAFIL Cause Dyspnoea exertional? 537 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 537 reports of Dyspnoea exertional have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 1.8% of all adverse event reports for TADALAFIL.
537
Reports of Dyspnoea exertional with TADALAFIL
1.8%
of all TADALAFIL reports
20
Deaths
220
Hospitalizations
How Dangerous Is Dyspnoea exertional From TADALAFIL?
Of the 537 reports, 20 (3.7%) resulted in death, 220 (41.0%) required hospitalization, and 14 (2.6%) were considered life-threatening.
Is Dyspnoea exertional Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 537 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Dyspnoea exertional?
TREPROSTINIL (3,378)
ALBUTEROL (2,190)
MACITENTAN (1,660)
AMBRISENTAN (1,655)
PREDNISONE (1,319)
TIOTROPIUM (1,137)
MEPOLIZUMAB (1,109)
BUDESONIDE\FORMOTEROL (1,038)
OMALIZUMAB (995)
EPOPROSTENOL (938)
Which TADALAFIL Alternatives Have Lower Dyspnoea exertional Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR